Dashboard
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Operating profit has grown by an annual rate -5.53% of over the last 5 years
3
Flat results in Jun 24
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.22%
0%
-25.22%
6 Months
-27.16%
0%
-27.16%
1 Year
-71.17%
0%
-71.17%
2 Years
-61.56%
0%
-61.56%
3 Years
-89.14%
0%
-89.14%
4 Years
-94.77%
0%
-94.77%
5 Years
-93.97%
0%
-93.97%
Creo Medical Group Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
79.03%
EBIT Growth (5y)
-5.53%
EBIT to Interest (avg)
-26.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.32
Tax Ratio
10.76%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.80
EV to EBIT
-1.38
EV to EBITDA
-1.53
EV to Capital Employed
0.73
EV to Sales
1.88
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
-53.14%
ROE (Latest)
7.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
27.20
25.20
7.94%
Operating Profit (PBDIT) excl Other Income
-27.70
-27.40
-1.09%
Interest
0.20
0.20
Exceptional Items
-0.00
-0.20
100.00%
Consolidate Net Profit
-26.90
-24.60
-9.35%
Operating Profit Margin (Excl OI)
-1,133.90%
-1,190.70%
5.68%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 7.94% vs 168.09% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -9.35% vs -21.18% in Dec 2021
About Creo Medical Group Plc 
Creo Medical Group Plc
Pharmaceuticals & Biotechnology
Creo Medical Group plc is a United Kingdom-based medical device company. The Company focuses on the field of surgical endoscopy. The Company focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer. The Company has developed CROMA, which is an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. The Company's surgical system CROMA combines bipolar radiofrequency for localized cutting and microwave energy for controlled coagulation, which provides physicians with simplified and controlled surgical solutions. The Company's pipeline portfolio of instruments is targeted at three therapeutic endoscopic specialties: lower GI; lung/bronchoscopy and upper GI.
Company Coordinates 
Company Details
Unit 2 Beaufort Park,, Beaufort Park Way , CHEPSTOW None : NP16 5UH
Registrar Details






